Pil-Ki Min1,2, Stephen Y Chan1. 1. Divisions of Cardiovascular and Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. 2. Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Abstract
BACKGROUND: Since their first description in mammalian cells, more than 2500 microRNA molecules have been predicted or verified within human cells. Recently, extracellular microRNAs have been described, protected from degradation by specialized packaging in extracellular vesicles or RNA-binding proteins. MATERIALS AND METHODS: We will discuss recent data regarding circulating microRNAs, their potential role as novel biomarkers and intercellular communicators, as well as future challenges of studying and applying such novel biology, particularly in the cardiovascular system. RESULTS: Circulating microRNAs have been proposed as attractive candidates as both diagnostic and prognostic biomarkers in various diseases, including a spectrum of cardiovascular conditions. Moreover, consistent with our evolving appreciation of the role of exosomes and microvesicles in intercellular communication, it has been proposed that delivery of active microRNAs to recipient tissues may serve as a primary mode of intercellular communication. Indeed, the transfer of functional microRNAs has been demonstrated in in vitro models and has been reported in a few in vivo contexts. In addition, therapeutic application of extracellular microRNAs has also been explored. CONCLUSION: Over recent years, increasing attention has been paid to the role of circulating miRNAs in cardiovascular disease. As biomarkers and intercellular communicators, circulating miRNAs could play important roles in the prediction, diagnosis and tailored treatment of cardiovascular diseases in the near future.
BACKGROUND: Since their first description in mammalian cells, more than 2500 microRNA molecules have been predicted or verified within human cells. Recently, extracellular microRNAs have been described, protected from degradation by specialized packaging in extracellular vesicles or RNA-binding proteins. MATERIALS AND METHODS: We will discuss recent data regarding circulating microRNAs, their potential role as novel biomarkers and intercellular communicators, as well as future challenges of studying and applying such novel biology, particularly in the cardiovascular system. RESULTS: Circulating microRNAs have been proposed as attractive candidates as both diagnostic and prognostic biomarkers in various diseases, including a spectrum of cardiovascular conditions. Moreover, consistent with our evolving appreciation of the role of exosomes and microvesicles in intercellular communication, it has been proposed that delivery of active microRNAs to recipient tissues may serve as a primary mode of intercellular communication. Indeed, the transfer of functional microRNAs has been demonstrated in in vitro models and has been reported in a few in vivo contexts. In addition, therapeutic application of extracellular microRNAs has also been explored. CONCLUSION: Over recent years, increasing attention has been paid to the role of circulating miRNAs in cardiovascular disease. As biomarkers and intercellular communicators, circulating miRNAs could play important roles in the prediction, diagnosis and tailored treatment of cardiovascular diseases in the near future.
Authors: Lijuan Guo; Yuanhua Yang; Jie Liu; Lei Wang; Jifeng Li; Ying Wang; Yan Liu; Song Gu; Huili Gan; Jun Cai; Jason X-J Yuan; Jun Wang; Chen Wang Journal: PLoS One Date: 2014-06-30 Impact factor: 3.240
Authors: Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley Journal: Nat Cell Biol Date: 2011-03-20 Impact factor: 28.824
Authors: Andrew C Morley-Smith; Adam Mills; Steven Jacobs; Bart Meyns; Filip Rega; André R Simon; John R Pepper; Alexander R Lyon; Thomas Thum Journal: Eur J Heart Fail Date: 2014-06-24 Impact factor: 15.534
Authors: Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert Journal: J Neural Transm (Vienna) Date: 2017-09-01 Impact factor: 3.575
Authors: Jonathan Florentin; Yi-Yin Tai; Thomas Bertero; Partha Dutta; Stephen Y Chan; Jingsi Zhao; Stéphanie Torrino; Lee Ohayon; Tomasz Brzoska; Ying Tang; Jimin Yang; Vinny Negi; Chen-Shan Chen Woodcock; Michael G Risbano; Seyed Mehdi Nouraie; Prithu Sundd Journal: Circ Res Date: 2020-06-04 Impact factor: 17.367